Shares of Ainos, Inc. (OTCMKTS:AIMD – Get Free Report) were up 2.9% during mid-day trading on Friday . The stock traded as high as $0.49 and last traded at $0.49. Approximately 1,037,908 shares were traded during mid-day trading, an increase of 18% from the average daily volume of 875,901 shares. The stock had previously closed at $0.48.
Ainos Stock Up 2.9 %
The company has a market cap of $6.89 million, a price-to-earnings ratio of -0.56 and a beta of 1.51. The firm’s fifty day moving average price is $0.62 and its 200-day moving average price is $0.55. The company has a current ratio of 1.92, a quick ratio of 1.45 and a debt-to-equity ratio of 0.08.
About Ainos
Ainos, Inc, a healthcare company, engages in developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a's broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan.
Read More
- Five stocks we like better than Ainos
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Institutional Investors Bet $1B on These 4 Stocks—Should You?
- Differences Between Momentum Investing and Long Term Investing
- One Must-Buy Stock and One to Avoid as Tariffs Shake the Market
- Diversification Can Smooth Returns And Mitigate Portfolio Risk
- These 4 Tech ETFs Just Hit 50-Day Lows—Time to Buy?
Receive News & Ratings for Ainos Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ainos and related companies with MarketBeat.com's FREE daily email newsletter.
